This inventor holds 1 USPTO granted patent. Top assignee: Allergan, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Vito De Novellis: Innovator in Pain Treatment
Introduction
Vito De Novellis is a notable inventor based in Santa Maria Capua Vetere, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuropathic pain. His innovative approach has led to the development of a unique method that addresses this challenging medical condition.
Latest Patents
Vito De Novellis holds a patent for a method for treating pain. The patent describes pharmaceutical compositions that are effective in alleviating neuropathic pain. The method involves the administration of a pain-ameliorating effective amount of a compound defined by a specific formula, where R is an alk(en)yl group, R1 is an alkylen(yl) group, n is 0 or 1, and Ar is a carbocyclic aryl group. This invention represents a significant advancement in pain management therapies.
Career Highlights
Vito De Novellis is currently associated with Allergan, Inc., a leading company in the pharmaceutical industry. His work at Allergan has allowed him to focus on developing innovative solutions for pain treatment. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, Vito has collaborated with several talented individuals, including Luciano De Petrocellis and Sabatino Malone. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pain treatment methodologies.
Conclusion
Vito De Novellis is a pioneering inventor whose work in pain treatment has the potential to improve the quality of life for many individuals suffering from neuropathic pain. His innovative methods and collaborations highlight the importance of research in developing effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
